Infectious Diseases News and Research

RSS

Novel candidate malaria vaccine confers high levels of durable protection

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites.

30 Jun 2021

Frequent testing increases chance of detecting COVID-19 infections

The chance of detecting the virus that causes COVID-19 increases with more frequent testing, no matter the type of test, a new study found. Both polymerase chain reaction and antigen tests, paired with rapid results reporting, can achieve 98% sensitivity if deployed at least every three days.

30 Jun 2021

Employed individuals more likely to be infected with the flu virus

A University of Arkansas researcher and international colleagues found that employed individuals, on average, are 35.3% more likely to be infected with the flu virus.

30 Jun 2021

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

The role of peripheral and brain infections in the development of Alzheimer's disease is the focus of new research at The University of Texas Health Science Center at Houston, funded with a $2 million grant from the National Institutes of Health.

30 Jun 2021

Assessing the safety of inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents

New clinical trial data, recently published in The Lancet’s Infectious Diseases, presents an initial report on the effect of an inactivated SARS-CoV-2 vaccine, CoronaVac, on children and adolescents from ages 3-17 in a double-blind, randomized setting.

30 Jun 2021

COVID-19 prevalence among hospitalized infants may depend on levels of community transmission

How common COVID-19 is among infants may depend on the degree of the pandemic virus circulating in a community, a new study finds.

30 Jun 2021

NIH-funded adjuvant improves the efficacy India's COVID-19 vaccine

An adjuvant developed with funding from the National Institutes of Health has contributed to the success of the highly efficacious COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere.

30 Jun 2021

Covid-19 patients experience a longer lasting reduced sense of taste and smell

Patients with mild Covid-19 infections experience a significantly increased longer lasting reduced sense of taste and smell.

29 Jun 2021

Six antibody features could be used to identify women at risk of placental malaria

Six antibody characteristics could help scientists identify which pregnant women are at risk of placental malaria infections, finds a study published today in eLife.

29 Jun 2021

How does dexamethasone therapy work in severe COVID-19?

The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper’s authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.

29 Jun 2021

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

Early in this century, post-SARS, and in a period when China started allowing more students and scientists to study abroad, collaboration and exchange between American and Chinese scientists blossomed.

29 Jun 2021

Rapid test kit for malaria delivers results in 30 minutes

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages.

29 Jun 2021

Immune response to FDA-approved vaccines is strong and potentially long-lasting

The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines.

29 Jun 2021

What's behind COVID-19 vaccine side effects?

A growing concern among coronavirus vaccines is the vaccine side effects. Fear or misinformation about side effects may fuel vaccine hesitancy, contributing to low vaccination rates. Australian researchers recently published an article in Science Immunology to discuss why people develop side effects and their benefits.

28 Jun 2021

Study examines the impact of hotel's community support during COVID-19 pandemic

Hotels that opened their doors to homeless people in their community during lockdown generated greater positive word-of-mouth marketing than those that offered free accommodation to frontline healthcare workers, finds new University research.

28 Jun 2021

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

Scientists isolated a molecule, extracted from the leaves of the European chestnut tree, with the power to neutralize dangerous, drug-resistant staph bacteria. Frontiers in Pharmacology published the finding, led by scientists at Emory University.

28 Jun 2021

What have been the main drivers of COVID-19's rapid spread in Brazil?

New research suggests that if a lockdown had been imposed earlier on in superspreader cities like São Paulo, mandatory road traffic restrictions had been enforced, and ICU beds had been allocated more equitably across geographical regions, Brazil’s experience of the COVID-19 pandemic might have been mitigated.

28 Jun 2021

Achieving gender equality within global health

News-Medical spoke to Dr. Claire Bayntun about her incredible career in global health, and how we can achieve gender equality within healthcare settings.

28 Jun 2021

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

The U.S. continues to see Covid-19 vaccinations gradually increasing nationwide, with nearly 66% of all adults now having at least one vaccine dose according to CDC's COVID Data Tracker, yet disparities have been noted in vaccination rates across races and geographic areas.

25 Jun 2021

UNC study provides important information for developing a viable vaccine against dengue

Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.

25 Jun 2021

Infectious Diseases News and Research

Novel candidate malaria vaccine confers high levels of durable protection

Frequent testing increases chance of detecting COVID-19 infections

Employed individuals more likely to be infected with the flu virus

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

Assessing the safety of inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents

COVID-19 prevalence among hospitalized infants may depend on levels of community transmission

NIH-funded adjuvant improves the efficacy India's COVID-19 vaccine

Covid-19 patients experience a longer lasting reduced sense of taste and smell

Six antibody features could be used to identify women at risk of placental malaria

How does dexamethasone therapy work in severe COVID-19?

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

Rapid test kit for malaria delivers results in 30 minutes

Immune response to FDA-approved vaccines is strong and potentially long-lasting

What's behind COVID-19 vaccine side effects?

Study examines the impact of hotel's community support during COVID-19 pandemic

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

What have been the main drivers of COVID-19's rapid spread in Brazil?

Achieving gender equality within global health

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

UNC study provides important information for developing a viable vaccine against dengue

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News